Skip to main content
OpenTrials
Completed

NCT Number: NCT05313412

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

This study is to compare the short-term clinical performance and subjective acceptance of two silicone hydrogel soft contact lenses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eurolens Research

Manchester, United Kingdom

About this study

This is a double-masked, randomized, bilateral crossover study to compare the short-term clinical performance of two silicone hydrogel soft contact lenses. Each lens type is worn for approximately six hours on separate study days, in random sequence.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • They are aged between 18 and 40 years.
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They have successfully worn contact lenses within six months of starting the study.
  • They can be satisfactorily fitted with the study contact lenses.
  • They have a contact lens spherical prescription between -0.25 to - 6.00D (inclusive) based on the ocular refraction.
  • They have a spectacle cylindrical correction of -0.75D or less in each eye based on the ocular refraction.
  • They own and habitually wear single vision spectacles.
  • They can attain at least 0.20 logMAR distance high contrast visual acuity in each eye, with the study lenses.
  • They agree not to participate in other clinical research while enrolled on this study.

Exclusion criteria

  • They have an ocular disorder which would normally contraindicate contact lens wear.
  • They have a systemic disorder which would normally contraindicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or breastfeeding.
  • They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (eg HIV) or a history of anaphylaxis or severe allergic reaction.
  • They have grade 3 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality, which would normally contraindicate contact lens wear.
  • They have taken part in any other clinical trial or research, within two weeks prior to starting this study, which may impact on this particular work.

Treatment and study plan

Lens A (comfilcon A lens)

Device

6 hours

Lens B (lehfilcon A lens)

Device

6 hours

Primary outcomes

  1. Ease of Lens Insertion

    Time frame: 6 hours

    Ease of Lens Insertion is measured on a scale of 0-100 (0-Unmanageable, Lenses impossible to insert; 100-Excellent. No problems with lens insertion)

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 6, 2022
Registry last updated
May 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.